Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Leukemia & Lymphoma
|
January 30, 2010
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study
Michael Crump, David Hedley, Suzanne Kamel-Reid, et al.
Cancer
|
November 6, 2009
Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter Study
Brad S Kahl, Nancy L Bartlett, John P Leonard, et al.
Leukemia & Lymphoma
|
March 11, 2020
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia
Sarit Assouline, Lilian Amrein, Raquel Aloyz, et al.
Leukemia & Lymphoma
|
January 18, 2024
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice
Versha Banerji, Andrew Aw, Nicole Laferriere, et al.
British Journal of Haematology
|
February 19, 2021
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study
Stephan Stilgenbauer, Francesc Bosch, Osman Ilhan, et al.
Blood Advances
|
May 13, 2020
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
Sarit Assouline, Shen Li, Christian Gisselbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study
Jonathan W Friedberg, Philip Cohen, Ling Chen, et al.
International Journal of Laboratory Hematology
|
January 5, 2023
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study
Kanza Naveed, Nicola Goldberg, Eliane Shore, et al.
Plos One
|
April 18, 2015
A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal
Ajit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Plos One
|
August 14, 2015
Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
Ajit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Leukemia & Lymphoma
|
January 30, 2010
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study
Michael Crump, David Hedley, Suzanne Kamel-Reid, et al.
Cancer
|
November 6, 2009
Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter Study
Brad S Kahl, Nancy L Bartlett, John P Leonard, et al.
Leukemia & Lymphoma
|
March 11, 2020
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia
Sarit Assouline, Lilian Amrein, Raquel Aloyz, et al.
Leukemia & Lymphoma
|
January 18, 2024
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice
Versha Banerji, Andrew Aw, Nicole Laferriere, et al.
British Journal of Haematology
|
February 19, 2021
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study
Stephan Stilgenbauer, Francesc Bosch, Osman Ilhan, et al.
Blood Advances
|
May 13, 2020
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
Sarit Assouline, Shen Li, Christian Gisselbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study
Jonathan W Friedberg, Philip Cohen, Ling Chen, et al.
International Journal of Laboratory Hematology
|
January 5, 2023
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study
Kanza Naveed, Nicola Goldberg, Eliane Shore, et al.
Plos One
|
April 18, 2015
A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal
Ajit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Plos One
|
August 14, 2015
Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
Ajit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Page
of 5